Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-10-15
1998-05-19
Gupta, Yogendra N.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540476, 540593, 540594, A61K 3155, C07D22316
Patent
active
057536449
ABSTRACT:
An object of the present invention is to provide a vasopressin antagonist and oxytocin antagonist.
The vasopressing antagonist and oxytocin antagonist according to the present invention contain, as the active ingredient, a benzoheterocyclic compound represented by the general formula (1): ##STR1## (wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and the carbon-carbon bond between 4- and 5-positions in the benzoazepine skeleton are the same as defined in claims 1, 2 and 3.) or salt thereof.
REFERENCES:
patent: 3516987 (1970-06-01), Charles et al.
patent: 3542760 (1970-11-01), Charles et al.
patent: 5258510 (1993-11-01), Ogawa et al.
patent: 5622947 (1997-04-01), Ogawa et al.
Kitano Kazuyoshi
Komatsu Hajime
Kondo Kazumi
Nakaya Kenji
Ogawa Hidenori
Gupta Yogendra N.
Otsuka Pharmaceutical Co. Ltd.
LandOfFree
Vasopressin antagonist and oxytocin antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vasopressin antagonist and oxytocin antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vasopressin antagonist and oxytocin antagonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1853162